Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia.

Hodge LS, Ziesmer SC, Yang ZZ, Secreto FJ, Gertz MA, Novak AJ, Ansell SM.

Blood. 2012 Nov 1;120(18):3774-82. doi: 10.1182/blood-2012-03-419440. Epub 2012 Sep 13.

2.

Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity.

Elsawa SF, Novak AJ, Ziesmer SC, Almada LL, Hodge LS, Grote DM, Witzig TE, Fernandez-Zapico ME, Ansell SM.

Blood. 2011 Nov 17;118(20):5540-9. doi: 10.1182/blood-2011-04-351742. Epub 2011 Sep 14.

3.

[Cytokine profiles of multiple myeloma and Waldenström macroglobulinemia].

Sedlaříková L, Sadílková K, Kubiczková L, Hájek R, Sevčíková S.

Klin Onkol. 2014;27(1):18-23. Review. Czech.

PMID:
24635433
4.

Bone marrow microenvironment in Waldenstrom's Macroglobulinemia.

Jalali S, Ansell SM.

Best Pract Res Clin Haematol. 2016 Jun;29(2):148-155. doi: 10.1016/j.beha.2016.08.016. Epub 2016 Sep 4. Review.

PMID:
27825460
5.

Nuclear BCL-10 expression is common in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia and does not correlate with p65 NF-kappaB activation.

Merzianu M, Jiang L, Lin P, Wang X, Weber DM, Vadhan-Raj S, Nguyen MH, Medeiros LJ, Bueso-Ramos CE.

Mod Pathol. 2006 Jul;19(7):891-8. Epub 2006 Apr 21.

6.

IL-1beta expression in IgM monoclonal gammopathy and its relationship to multiple myeloma.

Donovan KA, Lacy MQ, Gertz MA, Lust JA.

Leukemia. 2002 Mar;16(3):382-5.

7.

Modulation of the IL-6 Receptor α Underlies GLI2-Mediated Regulation of Ig Secretion in Waldenström Macroglobulinemia Cells.

Jackson DA, Smith TD, Amarsaikhan N, Han W, Neil MS, Boi SK, Vrabel AM, Tolosa EJ, Almada LL, Fernandez-Zapico ME, Elsawa SF.

J Immunol. 2015 Sep 15;195(6):2908-16. doi: 10.4049/jimmunol.1402974. Epub 2015 Aug 3.

8.

Targeting the bone marrow in Waldenstrom macroglobulinemia.

Ghobrial IM, Zhang Y, Liu Y, Ngo H, Azab F, Sacco A, Azab A, Maiso P, Morgan B, Quang P, Issa GC, Leleu X, Roccaro AM.

Clin Lymphoma Myeloma Leuk. 2011 Jun;11 Suppl 1:S65-9. doi: 10.1016/j.clml.2011.03.022. Epub 2011 Apr 30. Review.

9.

Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemia.

Leleu X, Xu L, Jia X, Sacco A, Farag M, Hunter ZR, Moreau AS, Ngo HT, Hatjiharissi E, Ho AW, Santos DD, Adamia S, O'Connor K, Ciccarelli B, Soumerai J, Manning RJ, Patterson CJ, Roccaro AM, Ghobrial IM, Treon SP.

Blood. 2009 Jan 15;113(3):626-34. doi: 10.1182/blood-2007-10-116848. Epub 2008 Nov 3.

10.

t(1;14) and t(11;18) in the differential diagnosis of Waldenström's macroglobulinemia.

Ye H, Chuang SS, Dogan A, Isaacson PG, Du MQ.

Mod Pathol. 2004 Sep;17(9):1150-4.

11.

Bone-marrow plasma cell burden correlates with IgM paraprotein concentration in Waldenstrom macroglobulinaemia.

Pasricha SR, Juneja SK, Westerman DA, Came NA.

J Clin Pathol. 2011 Jun;64(6):520-3. doi: 10.1136/jcp.2010.088591. Epub 2011 Apr 6.

PMID:
21471142
12.

B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.

Sugai S, Takiguchi T, Hirose Y, Konaka Y, Shimizu S, Konda S.

Jpn J Clin Oncol. 1983 Sep;13(3):533-42.

PMID:
6417376
13.

Hypoxia promotes dissemination and colonization in new bone marrow niches in Waldenström macroglobulinemia.

Muz B, de la Puente P, Azab F, Ghobrial IM, Azab AK.

Mol Cancer Res. 2015 Feb;13(2):263-72. doi: 10.1158/1541-7786.MCR-14-0150. Epub 2014 Sep 17.

14.

FGFR3 is overexpressed waldenstrom macroglobulinemia and its inhibition by Dovitinib induces apoptosis and overcomes stroma-induced proliferation.

Azab AK, Azab F, Quang P, Maiso P, Sacco A, Ngo HT, Liu Y, Zhang Y, Morgan BL, Roccaro AM, Ghobrial IM.

Clin Cancer Res. 2011 Jul 1;17(13):4389-99. doi: 10.1158/1078-0432.CCR-10-2772. Epub 2011 Apr 26.

15.

Eph-B2/ephrin-B2 interaction plays a major role in the adhesion and proliferation of Waldenstrom's macroglobulinemia.

Azab F, Azab AK, Maiso P, Calimeri T, Flores L, Liu Y, Quang P, Roccaro AM, Sacco A, Ngo HT, Zhang Y, Morgan BL, Carrasco RD, Ghobrial IM.

Clin Cancer Res. 2012 Jan 1;18(1):91-104. doi: 10.1158/1078-0432.CCR-11-0111. Epub 2011 Oct 18.

16.

Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia associated with Hodgkin disease. A report of two cases.

Rosales CM, Lin P, Mansoor A, Bueso-Ramos C, Medeiros LJ.

Am J Clin Pathol. 2001 Jul;116(1):34-40.

PMID:
11447749
17.

Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1.

Hodge LS, Novak AJ, Grote DM, Braggio E, Ketterling RP, Manske MK, Price Troska TL, Ziesmer SC, Fonseca R, Witzig TE, Morice WG, Gertz MA, Ansell SM.

Blood. 2011 May 12;117(19):e190-7. doi: 10.1182/blood-2010-12-326868. Epub 2011 Mar 17.

18.
19.

B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia.

Elsawa SF, Novak AJ, Grote DM, Ziesmer SC, Witzig TE, Kyle RA, Dillon SR, Harder B, Gross JA, Ansell SM.

Blood. 2006 Apr 1;107(7):2882-8. Epub 2005 Nov 22.

20.

IgM monoclonal gammopathy/Waldenström's macroglobulinemia: a morphological and immunophenotypic study of the bone marrow.

Feiner HD, Rizk CC, Finfer MD, Bannan M, Gottesman SR, Chuba JV, Amorosi E.

Mod Pathol. 1990 May;3(3):348-56.

PMID:
2114024

Supplemental Content

Support Center